Axogen AXGN

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.04 (-0.23%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Axogen (AXGN)
    Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $17.73

    • Market Cap

      $786.22 Million

    • Price-Earnings Ratio

      -77.09

    • Total Outstanding Shares

      44.01 Million Shares

    • Total Employees

      452

    • Dividend

      No dividend

    • IPO Date

      December 17, 1986

    • SIC Description

      Electromedical & Electrotherapeutic Apparatus

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      13631 progress blvd., Alachua, FL, 32615

    • Homepage

      https://www.axogeninc.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow From Operating Activities, Continuing$4.54 Million
    Net Cash Flow From Investing Activities, Continuing$-10.30 Million
    Net Cash Flow From Financing Activities, Continuing$2.29 Million
    Net Cash Flow, Continuing$-3.47 Million
    Net Cash Flow$-3.47 Million
    Net Cash Flow From Operating Activities$4.54 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Benefits Costs and Expenses$145.26 Million
    Nonoperating Income/Loss$-6.68 Million
    Net Income/Loss Attributable To Noncontrolling Interest$0
    Basic Average Shares$44.26 Million
    Income/Loss From Continuing Operations After Tax$-9.96 Million
    Other Operating Expenses$117.50 Million

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss$-9.96 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss Attributable To Parent$-9.96 Million
    Other Comprehensive Income/Loss$0

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Long-term Debt$47.50 Million
    Equity Attributable To Noncontrolling Interest$0
    Liabilities$99.82 Million
    Intangible Assets$5.58 Million
    Other Non-current Liabilities$21.71 Million
    Current Liabilities$30.61 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AXGN from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.